IMIDAZOQUINOLINES AS DUAL LIPID KINASE AND mTOR INHIBITORS

Title:

IMIDAZOQUINOLINES AS DUAL LIPID KINASE AND mTOR INHIBITORS

Document Type and Number:

Japanese Patent JP2016041760

Kind Code:

A

Abstract:

PROBLEM TO BE SOLVED: To provide pharmaceutical preparations for the treatment of mammalian target-of-rapamycin (mTOR) kinase dependent diseases.SOLUTION: The invention relates to the use of compounds of formula (I) in the treatment of mammalian target-of-rapamycin (mTOR) kinase dependent diseases, methods of using the compounds in the treatment of the diseases in a warm-blooded animal, especially a human, pharmaceutical preparations comprising the compounds for the treatment of the diseases, and the compounds for use in the treatment of the diseases.SELECTED DRAWING: None

More Like This:

JP2001089476	NEW QUINOLONE FUSED RING DERIVATIVE
WO/2002/046188	AMIDO ETHER SUBSTITUTED IMIDAZOQUINOLINES
WO/2014/028597	3-CYCLOHEXENYL AND CYCLOHEXYL SUBSTITUTED INDOLE AND INDAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF

Inventors:

SASKIA MARIA BRACHMANN
PETER FINAN
CHRISTINE FRITSCH
GARCIA-ECHEVERRIA CARLOS
MAIRA SAUVEUR-MICHEL
MURPHY LEON
NICKLIN PAUL LESLIE

Application Number:

JP2015249902A

Publication Date:

March 31, 2016

Filing Date:

December 22, 2015

Export Citation:

Click for automatic bibliography generation Help

Assignee:

NOVARTIS AG

International Classes:

A61K31/4745; A61K31/496; A61P1/00; A61P3/10; A61P9/10; A61P9/12; A61P11/00; A61P13/12; A61P17/00; A61P21/00; A61P25/00; A61P25/02; A61P25/14; A61P25/16; A61P25/28; A61P27/02; A61P29/00; A61P31/04; A61P31/06; A61P31/12; A61P31/18; A61P35/00; A61P35/02; A61P37/02; A61P37/06; A61P43/00

Domestic Patent References:

JP5902141B2

2016-04-13

Foreign References:

WO2006122806A2

2006-11-23

Attorney, Agent or Firm:

Hiroshi Kobayashi
Norio Omori
Uetake Yukiko
Yasuhito Suzuki

Previous Patent: FORMATIONS APPLICABLE TO BODY SURFACE

Next Patent: METHOD OF TREATING POLYCYSTIC KIDNEY DISEASES WITH CERAMIDE DERIVATIVES